NO20011966D0 - Serin-protease-inhibitor - Google Patents

Serin-protease-inhibitor

Info

Publication number
NO20011966D0
NO20011966D0 NO20011966A NO20011966A NO20011966D0 NO 20011966 D0 NO20011966 D0 NO 20011966D0 NO 20011966 A NO20011966 A NO 20011966A NO 20011966 A NO20011966 A NO 20011966A NO 20011966 D0 NO20011966 D0 NO 20011966D0
Authority
NO
Norway
Prior art keywords
protease inhibitor
serine protease
serine
inhibitor
protease
Prior art date
Application number
NO20011966A
Other languages
English (en)
Other versions
NO20011966L (no
Inventor
Cornelis Marius Timmers
Johannes Bernardus Ma Rewinkel
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20011966D0 publication Critical patent/NO20011966D0/no
Publication of NO20011966L publication Critical patent/NO20011966L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO20011966A 1998-10-23 2001-04-20 Serin-protease-inhibitor NO20011966L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203559 1998-10-23
PCT/EP1999/007928 WO2000024718A1 (en) 1998-10-23 1999-10-19 Serine protease inhibitor

Publications (2)

Publication Number Publication Date
NO20011966D0 true NO20011966D0 (no) 2001-04-20
NO20011966L NO20011966L (no) 2001-04-23

Family

ID=8234249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011966A NO20011966L (no) 1998-10-23 2001-04-20 Serin-protease-inhibitor

Country Status (24)

Country Link
US (1) US6903107B1 (no)
EP (1) EP1123280A1 (no)
JP (1) JP2002528438A (no)
KR (1) KR20010075648A (no)
CN (1) CN1146543C (no)
AR (1) AR020922A1 (no)
AU (1) AU763667B2 (no)
BR (1) BR9914694A (no)
CA (1) CA2346990A1 (no)
CO (1) CO5140114A1 (no)
CZ (1) CZ20011440A3 (no)
HU (1) HUP0103806A3 (no)
ID (1) ID29885A (no)
IL (1) IL142398A0 (no)
NO (1) NO20011966L (no)
NZ (1) NZ511067A (no)
PE (1) PE20001283A1 (no)
PL (1) PL347948A1 (no)
RU (1) RU2232760C2 (no)
SK (1) SK5372001A3 (no)
TR (1) TR200101120T2 (no)
TW (1) TW575567B (no)
WO (1) WO2000024718A1 (no)
ZA (1) ZA200102970B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10046272A1 (de) * 2000-09-19 2002-03-28 Merck Patent Gmbh Aminoheterocyclen (Faktor Xa Inhibitoren 14)
EP1569912B1 (en) 2002-12-03 2015-04-29 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
GB0309850D0 (en) 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
DK1667991T3 (da) 2003-09-16 2008-08-18 Astrazeneca Ab Quinazolinderivater som tyrosinkinaseinhibitorer
GB0322409D0 (en) 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
GB0326459D0 (en) 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
ATE413389T1 (de) 2004-02-03 2008-11-15 Astrazeneca Ab Chinazolinderivate
EP1899322B1 (en) 2005-06-28 2009-09-02 Sanofi-Aventis Isoquinoline derivatives as inhibitors of rho-kinase
SI1912949T1 (sl) 2005-07-26 2011-12-30 Sanofi Sa Cikloheksilamin izokinolonski derivati kot inhibitorji Rho-kinaze
PT1910333E (pt) * 2005-07-26 2013-08-01 Sanofi Sa Derivados de isoquinolona substituída com piperidinilo como inibidores da rho-cinase
TWI389899B (zh) 2006-08-08 2013-03-21 Msd Oss Bv 具口服活性之凝血酶抑制劑
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
CA2673918C (en) * 2006-12-27 2015-02-17 Sanofi-Aventis Substituted isoquinoline and isoquinolinone derivatives
JP5421783B2 (ja) * 2006-12-27 2014-02-19 サノフイ Rhoキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
AU2007338410B2 (en) 2006-12-27 2012-08-16 Sanofi-Aventis Cycloalkylamine substituted isoquinoline derivatives
RU2009128688A (ru) * 2006-12-27 2011-02-10 Санофи-Авентис (Fr) Замещенные циклоалкиламином производные изохинолина и изохинолинона
JP5313919B2 (ja) 2006-12-27 2013-10-09 サノフイ 新規な置換イソキノリン及びイソキノリノン誘導体
RU2457203C2 (ru) 2006-12-27 2012-07-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолона
PT2102164E (pt) * 2006-12-27 2011-01-21 Sanofi Aventis Derivados de isoquinolina e de isoquinolinona substituída com cicloalquilamina
WO2008095847A1 (de) 2007-02-06 2008-08-14 Boehringer Ingelheim International Gmbh Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US8497369B2 (en) 2008-02-07 2013-07-30 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production
NZ589883A (en) 2008-05-13 2012-06-29 Astrazeneca Ab Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy} quinazoline
JP5715561B2 (ja) * 2008-06-24 2015-05-07 サノフイ 二及び多環式置換イソキノリン及びイソキノリノン誘導体
JP5713893B2 (ja) 2008-06-24 2015-05-07 サノフイ Rho−キナーゼ阻害剤としての置換イソキノリン類及びイソキノリノン類
JP5714485B2 (ja) 2008-06-24 2015-05-07 サノフイ 6−置換イソキノリン類及びイソキノリノン類
EP2313397B1 (de) 2008-08-08 2016-04-20 Boehringer Ingelheim International GmbH Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
CN103946388A (zh) * 2011-06-28 2014-07-23 英伊布里克斯有限责任公司 Wap结构域融合多肽及其使用方法
SG10201601621PA (en) * 2011-06-28 2016-04-28 Inhibrx Llc Serpin fusion polypeptides and methods of use thereof
US10400029B2 (en) 2011-06-28 2019-09-03 Inhibrx, Lp Serpin fusion polypeptides and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473501A (en) * 1981-05-04 1984-09-25 G. D. Searle & Co. Dihydro azino isoquinolines
GB8908229D0 (en) 1989-04-12 1989-05-24 Smithkline Beckman Intercredit Compounds
CZ327698A3 (cs) 1996-04-13 1999-05-12 Astra Pharmaceuticals Ltd. Aminoisochinolinový a aminothienopyridinový derivát a jejich použití jako protizánětlivých přípravků
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
AU753675B2 (en) * 1998-03-19 2002-10-24 Ajinomoto Co., Inc. Aminoisoquinoline derivatives

Also Published As

Publication number Publication date
CN1348444A (zh) 2002-05-08
PL347948A1 (en) 2002-04-22
IL142398A0 (en) 2002-03-10
KR20010075648A (ko) 2001-08-09
AR020922A1 (es) 2002-06-05
PE20001283A1 (es) 2000-11-20
WO2000024718A1 (en) 2000-05-04
SK5372001A3 (en) 2001-11-06
TR200101120T2 (tr) 2001-08-21
AU6341399A (en) 2000-05-15
EP1123280A1 (en) 2001-08-16
CN1146543C (zh) 2004-04-21
AU763667B2 (en) 2003-07-31
HUP0103806A2 (hu) 2002-02-28
ZA200102970B (en) 2002-07-10
JP2002528438A (ja) 2002-09-03
BR9914694A (pt) 2001-07-10
ID29885A (id) 2001-10-18
HUP0103806A3 (en) 2002-03-28
TW575567B (en) 2004-02-11
CA2346990A1 (en) 2000-05-04
CO5140114A1 (es) 2002-03-22
NZ511067A (en) 2003-03-28
US6903107B1 (en) 2005-06-07
CZ20011440A3 (cs) 2001-09-12
RU2232760C2 (ru) 2004-07-20
NO20011966L (no) 2001-04-23

Similar Documents

Publication Publication Date Title
NO20011966L (no) Serin-protease-inhibitor
DE69823178D1 (de) Serine protease inhibitoren
NO20012980L (no) Proteaseinhibitorer
NO992734L (no) Serin-protease inhibitorer
NO995433D0 (no) Protease-inhibitorer
NO983688D0 (no) Serin-protease-inhibitorer
ZA992447B (en) Quinoxalinones as serine protease inhibitors.
ID25897A (id) Variant-variant protease tersubstitusi banyak
NO20004696D0 (no) Kinoloner som serinproteaseinhibitorer
NO995435D0 (no) Protease-inhibitorer
DE69730871D1 (de) Serine-protease-inhibitoren
DE69714222D1 (de) Serine-protease-inhibitoren
NO995268D0 (no) Proteaseinhibitorer
NO995434D0 (no) Proteaseinhibitorer
IS5590A (is) Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar
DE59806475D1 (de) Urokinase-inhibitoren
NO20011388D0 (no) Hydroksamat-inneholdende cystein- og serinproteasehemmere
GB9800817D0 (en) Serine protease inhibitors
DZ2815A1 (fr) Inhibiteurs de protéase.
DE69903779D1 (de) Inhibitor- Schalter
EP1206233A4 (en) Serine proteases
EP1132473A4 (en) NEW SERINE PROTEASE BSSP6
EP0949334A4 (en) NEW SERINE PROTEASE.
EP1195163A4 (en) Serine protease inhibitors
DE59905921D1 (de) Kältegerät

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application